Anaplastic large cell lymphoma (ALCL), ALK-negative, primarily affects lymph nodes in the axillary and upper limb regions. This aggressive form of non-Hodgkin lymphoma is characterized by the proliferation of large atypical lymphoid cells. Accurate coding with ICD-10 Code C84.74 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code C84.74 represents anaplastic large cell lymphoma that is anaplastic lymphoma kinase (ALK) negative, specifically affecting the lymph nodes in the axilla and upper limb. This code is used in clinical documentation and billing when diagnosing patients with this specific subtype of lymphoma, which is crucial for treatment planning and healthcare resource allocation.
Anaplastic large cell lymphoma (ALCL), ALK-negative, is a rare and aggressive form of non-Hodgkin lymphoma that typically presents with lymphadenopathy in the axillary and upper limb regions. The etiology is often linked to genetic mutations and environmental factors. Prompt diagnosis and treatment are critical due to its aggressive nature and potential for systemic involvement.
ICD-10 Code C84.74 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients diagnosed with anaplastic large cell lymphoma, ALK-negative. This code aids in capturing the patient's symptoms, guiding clinical assessments, and formulating treatment plans in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.74 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of anaplastic large cell lymphoma, ALK-negative. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
The management of anaplastic large cell lymphoma, ALK-negative, often requires urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.74 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C84.74 for Anaplstc lg cell lymph, ALK-neg, nodes of axla and upr limb
What are the common symptoms of anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and general malaise.
How is anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a biopsy of the affected lymph nodes, followed by histological examination to identify large atypical lymphoid cells.
What treatment options are available for this condition?
Treatment usually involves chemotherapy, and in some cases, targeted therapies may be considered. Supportive care is also essential to manage symptoms.
Is anaplastic large cell lymphoma contagious?
No, anaplastic large cell lymphoma is not contagious. It is a type of cancer that arises from lymphoid tissue and is not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes